Citations

Citations to this article as recorded by  

• Diagnostic utilities of washout CYFRA 21-1 combined with washout thyroglobulin for metastatic lymph nodes in thyroid cancer: a prospective study
  Joonseon Park, Solji An, Kwangsoon Kim, Jeong Soo Kim, Chan Kwon Jung, Ja Seong Bae
  Scientific Reports.2024;[Epub]     CrossRef
• BRAFV600E Positivity-Dependent Effect of Age on Papillary Thyroid Cancer Recurrence Risk
  Joonseon Park, Solji An, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim
  Cancers.2023; 15(22): 5395.     CrossRef
• TROP-2 and 5hmC expression in follicular-patterned thyroid neoplasm emphasizing tiny well-formed papillae
  Jae Yeon Seok, Xuemo Fan
  Annals of Diagnostic Pathology.2022; 57: 151903.     CrossRef
• Null Association between BRAF V600E Mutation and Tumor Recurrence in Patients with Papillary Thyroid Microcarcinoma in South Korea
  Ji Yoon Kim, Kyoung Jin Kim, Jae Hyun Bae, Joo Hyung Kim, Nam Hoon Kim, Hee Young Kim, Hoon Yub Kim, Seung-Kuk Baek, Sin Gon Kim, Kwang Yoon Jung, Kyeong Jin Kim
  International Journal of Thyroidology.2021; 14(2): 135.     CrossRef
• Evaluation of the expression levels of BRAFV600E mRNA in primary tumors of thyroid cancer using an ultrasensitive mutation assay
  Tien Viet Tran, Kien Xuan Dang, Quynh Huong Pham, Ung Dinh Nguyen, Nhung Thi Trang Trinh, Luong Van Hoang, Son Anh Ho, Ba Van Nguyen, Duc Trong Nguyen, Dung Tuan Trinh, Dung Ngoc Tran, Arto Orpana, Ulf-Håkan Stenman, Jakob Stenman, Tho Huu Ho
  BMC Cancer.2020;[Epub]     CrossRef
• The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
  Irene Vanni, Enrica Teresa Tanda, Francesco Spagnolo, Virginia Andreotti, William Bruno, Paola Ghiorzo
  Frontiers in Molecular Biosciences.2020;[Epub]     CrossRef
• Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans
  Sue Youn Kim, Taeeun Kim, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim, Chan Kwon Jung
  Journal of Pathology and Translational Medicine.2020; 54(4): 310.     CrossRef
• Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance
  Giorgia Acquaviva, Michela Visani, Andrea Repaci, Kerry J Rhoden, Dario de Biase, Annalisa Pession, Tallini Giovanni
  Histopathology.2018; 72(1): 6.     CrossRef
• Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues
  Nunthawut Chat-Uthai, Pichpisith Vejvisithsakul, Sutthirat Udommethaporn, Puttarakun Meesiri, Chetiya Danthanawanit, Yannawan Wongchai, Chinachote Teerapakpinyo, Shanop Shuangshoti, Naravat Poungvarin, John Souglakos
  PLOS ONE.2018; 13(6): e0198795.     CrossRef
• T-blocker: a simple and robust probe-free quantitative PCR assay to detect somatic mutations down to 0.1% frequency
  Hanyoup Kim, Aaron E Ruby, Harini G Shandilya, Arvind K Virmani, Nandita Rahman, Christina M Strange, Jarkko Huuskonen
  BioTechniques.2018; 65(4): 205.     CrossRef
• The usefulness of a novel fully automated PCR-based Idylla test for detection of the BRAF V600E mutation in thyroid tissue: comparison with PNA-clamping PCR, real-time PCR and pyrosequencing
  Min-Kyung Yeo, Min-Kyu Jung, Su-Yel Lee, Yong-Moon Lee, Gang Min Hur, Jin-Man Kim
  Journal of Clinical Pathology.2017; 70(3): 260.     CrossRef
• KRAS mutation analysis of washing fluid from endoscopic ultrasound-guided fine needle aspiration improves cytologic diagnosis of pancreatic ductal adenocarcinoma
  Joo Kyung Park, Yoon Jung Lee, Jong Kyun Lee, Kyu Taek Lee, Yoon-La Choi, Kwang Hyuck Lee
  Oncotarget.2017; 8(2): 3519.     CrossRef
• Application of Peptide Nucleic Acid-based Assays Toward Detection of Somatic Mosaicism
  Christopher S Hong, Chunzhang Yang, Zhengping Zhuang
  Molecular Therapy - Nucleic Acids.2016; 5: e314.     CrossRef
• Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma
  Seo Ki Kim, Jun Ho Lee, Jung-Woo Woo, Inhye Park, Jun-Ho Choe, Jung-Han Kim, Jee Soo Kim
  Medicine.2015; 94(21): e760.     CrossRef
• The association between BRAF V600E mutation and pathological features in PTC
  Xin Liu, Kangkang Yan, Xuejun Lin, Longyu Zhao, Wenxiu An, Chunpeng Wang, Xiaodong Liu
  European Archives of Oto-Rhino-Laryngology.2014; 271(11): 3041.     CrossRef
• Recurrent Thyroid Papillary Carcinoma in Children Under Ten Years Old: Report of Two Cases and Literature Review
  Byeong-Joo Noh, Ji-Youn Sung, Youn-Wha Kim, Yong-Koo Park
  Korean Journal of Pathology.2014; 48(4): 297.     CrossRef
• KRASMutation Detection in Non-small Cell Lung Cancer Using a Peptide Nucleic Acid-Mediated Polymerase Chain Reaction Clamping Method and Comparative Validation with Next-Generation Sequencing
  Boram Lee, Boin Lee, Gangmin Han, Mi Jung Kwon, Joungho Han, Yoon-La Choi
  Korean Journal of Pathology.2014; 48(2): 100.     CrossRef
• VE1 immunohistochemistry in pituitary adenomas is not associated with BRAF V600E mutation
  Jan Sperveslage, Midea Gierke, David Capper, Jürgen Honegger, Bence Sipos, Rudi Beschorner, Jens Schittenhelm
  Acta Neuropathologica.2013; 125(6): 911.     CrossRef
• BRAF Mutations in Iranian Patients with Papillary Thyroid Carcinoma
  Nastran Ranjbari, Sara Almasi, Javad Mohammadi-asl, Fakher Rahim
  Asian Pacific Journal of Cancer Prevention.2013; 14(4): 2521.     CrossRef